Sai Parenterals Limited has informed the Exchange regarding Outcome of Board Meeting held on April 20, 2026.
SAIPARENT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sai Parenterals Limited's board approved an unsecured loan of up to AUD 1.75 million or SGD 1.610 million (approximately INR 11.91 crore) to its wholly owned subsidiary, Sai Singapore Pte. Ltd. The funds will be used for downstream investment in Noumed Pharmaceuticals Pty Limited, Australia, which is a step-down subsidiary of the company. The board meeting was held on April 20, 2026, from 12:00 noon to 2:40 PM.
This is routine internal funding within the corporate structure and does not represent any material change to Sai Parenterals' business or shareholding structure. Shareholders should not expect any significant impact on the stock from this announcement.